DUBAI, May 18 / WAM / Dubai will host the “Precision Medicine Exhibition and Conference 2023” on May 23 and 24 at the Dubai World Trade Center, with the participation of a group of experts, specialized doctors and health care leaders from all over the world.
The event represents a unique platform for cooperation and knowledge exchange by reviewing the practical and clinical application of precision medicine, and its sessions include interactive presentations highlighting the latest discoveries and technologies developed in this field.
Precision Medicine Exhibition and Conference 2023 is supported by the Ministry of Industry and Advanced Technology, the Ministry of Health and Prevention, the Abu Dhabi Department of Health and the Dubai Health Authority.
David Stradling, Director of Events for the 2023 Precision Medicine Exhibition and Conference, stated that the value of the global market for precision medicine amounted to about $73.5 billion in 2022, and he expected this value to exceed $175 billion by 2030. He attributed the expected rise to developed markets and services provided by specialized companies in this field.
For her part, Aisha Al-Mulla, Director of the Friends of Cancer Patients Association, said that precision medicine would support diagnosis and drug treatment and improve health outcomes by adapting the treatment plan according to the needs of cancer patients individually.
Speakers at the conference, experts and specialists, focus on exploring the actual application of genetics and genomic systems and the importance of moving towards health care dedicated to treating patients.
A group of health care providers and companies will participate in the exhibition accompanying the conference, which will display the latest advanced technologies and diagnostic health care solutions in the field of precision medicine.
In conjunction with the Precision Medicine Exhibition and Conference 2023, a forum dedicated to innovation and investment in the field of health technology will be held. Institute of Technological Innovation, Leader Life Sciences, Thermo Fisher Scientific, and Biorus.
